Introduction To High Content Screening

Regular price €124.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
assays development
Category=PN
cellular imaging
data analysis
drug discovery
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
high content screening

Product details

  • ISBN 9780470624562
  • Weight: 603g
  • Dimensions: 164 x 244mm
  • Publication Date: 31 Dec 2014
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: US
  • Product Form: Hardback
Secure checkout Fast Shipping Easy returns


Using a collaborative and interdisciplinary author base with experience in the pharmaceutical industry and academia, this book is a practical resource for high content (HC) techniques.

• Instructs readers on the fundamentals of high content screening (HCS) techniques
• Focuses on practical and widely-used techniques like image processing and multiparametric assays
• Breaks down HCS into individual modules for training and connects them at the end
• Includes a tutorial chapter that works through sample HCS assays, glossary, and detailed appendices

Steven Haney is a Senior Research Advisor and Group Leader at Eli Lilly and Company. He edited the book High Content Screening: Science, Techniques, and Applications (Wiley, 2008).

Douglas Bowman
is an Associate Scientific Fellow at Takeda Pharmaceuticals.

Arijit Chakravarty
is the Director of Modeling and Simulation (DMPK) at Takeda Pharmaceuticals.

Anthony Davies
is Center Director, Translational Cell Imaging, Queensland University Of Technology, Queensland, Australia.

Caroline Shamu
is the Director of the ICCB-Longwood Screening Facility at Harvard Medical School.